{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:41:52Z","timestamp":1792564912161,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021779","name":"Perpetual","doi-asserted-by":"publisher","award":["IPAP2023\/1338"],"award-info":[{"award-number":["IPAP2023\/1338"]}],"id":[{"id":"10.13039\/501100021779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Little is known about the underlying cause contributing to the association between Osteoporosis (OP) and Alzheimer\u2019s disease (AD). This review highlights the emerging role of sclerostin, a protein mainly produced by osteocytes, in the newly discovered crosstalk between bone and brain, with a focus on its potential contribution to the relationship between OP and AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Circulating sclerostin levels increase with aging and are positively associated with brain amyloid-\u03b2 burden in older adults. Studies demonstrate that elevated sclerostin can cross the blood-brain barrier, promote amyloid-\u03b2 peptide deposition, and impair synaptic plasticity by suppressing Wnt\/\u03b2-catenin signalling, whereas sclerostin inhibition restores neuronal plasticity and attenuates AD pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Sclerostin represents a promising target in the bone-brain interaction pathway. Its dual role as a measurable circulating biomarker and a modifiable component offers new opportunities for early risk assessment and therapeutic repurposing. Future longitudinal and interventional studies are essential to confirm the association between sclerostin and risk of AD, and to clarify whether targeting sclerostin can delay the onset of the disease or modify its trajectory.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11914-026-00993-y","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:51:19Z","timestamp":1792561879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteoporosis and Alzheimer\u2019s Disease: The Role of Sclerostin"],"prefix":"10.1007","volume":"24","author":[{"given":"Lorel\u00e9","family":"Gagiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Blakeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7283-626X","authenticated-orcid":false,"given":"Christopher","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-4654","authenticated-orcid":false,"given":"Jun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"993_CR1","volume-title":"Endotext","author":"CJ Rosen","year":"2020","unstructured":"Rosen CJ. The epidemiology and pathogenesis of osteoporosis. In: Endotext. South Dartmouth (MA): MDText.com, Inc. 2020."},{"key":"993_CR2","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","volume":"2","author":"AM Wu","year":"1990","unstructured":"Wu AM, Bisignano C, James SL, Abady GG, Abedi A, Abu-Gharbieh E, et al. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev. 1990;2:e580. https:\/\/doi.org\/10.1016\/S2666-7568(21)00172-0.","journal-title":"Lancet Healthy Longev"},{"key":"993_CR3","doi-asserted-by":"publisher","unstructured":"Sarafrazi N, Wambogo EA, Shepherd JA. Osteoporosis or low bone mass in older adults: United States, 2017\u20132018. NCHS Data Brief. 2021;405:1\u20138. https:\/\/doi.org\/10.15620\/CDC:103477","DOI":"10.15620\/CDC:103477"},{"key":"993_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874609814666210302085232","volume":"15","author":"JO Ogbodo","year":"2021","unstructured":"Ogbodo JO, Agbo CP, Njoku UO, Ogugofor MO, Egba SI, Ihim SA, et al. Alzheimer\u2019s Disease: Pathogenesis and Therapeutic Interventions. Curr Aging Sci. 2021;15:2\u201325. https:\/\/doi.org\/10.2174\/1874609814666210302085232","journal-title":"Curr Aging Sci"},{"key":"993_CR5","doi-asserted-by":"publisher","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s & Dementia 2023;19:1598\u2013695. https:\/\/doi.org\/10.1002\/ALZ.13016","DOI":"10.1002\/ALZ.13016"},{"key":"993_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/JAMA.2024.27154","volume":"333","author":"WK Nicholson","year":"2025","unstructured":"Nicholson WK, Silverstein M, Wong JB, Chelmow D, Coker TR, Davis EM, et al. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMA. 2025;333:498\u2013508. https:\/\/doi.org\/10.1001\/JAMA.2024.27154","journal-title":"JAMA"},{"key":"993_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031692","volume":"101","author":"X Yu","year":"2022","unstructured":"Yu X, Sun S, Zhang S, Hao Q, Zhu B, Teng Y, et al. A pooled analysis of the association between sarcopenia and osteoporosis. Medicine (Baltimore). 2022;101:e31692. https:\/\/doi.org\/10.1097\/MD.0000000000031692.","journal-title":"Medicine (Baltimore)"},{"key":"993_CR8","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/JCSM.13485","volume":"15","author":"N Amini","year":"2024","unstructured":"Amini N, Ibn Hach M, Lapauw L, Dupont J, Vercauteren L, Verschueren S, et al. Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer\u2019s disease and other forms of dementia. J Cachexia Sarcopenia Muscle. 2024;15:1240\u201353. https:\/\/doi.org\/10.1002\/JCSM.13485.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"993_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/S11914-023-00851-1","volume":"22","author":"HS Wang","year":"2024","unstructured":"Wang HS, Karnik SJ, Margetts TJ, Plotkin LI, Movila A, Fehrenbacher JC, et al. Mind Gaps and Bone Snaps: Exploring theConnection Between Alzheimer\u2019s Disease and Osteoporosis. Curr Osteoporos Rep. 2024;22:483. https:\/\/doi.org\/10.1007\/S11914-023-00851-1","journal-title":"Curr Osteoporos Rep"},{"key":"993_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/S11914-023-00848-W","volume":"22","author":"TJ Margetts","year":"2024","unstructured":"Margetts TJ, Wang HS, Karnik SJ, Plotkin LI, Movila A, Oblak AL, et al. From the mind to the spine: the intersecting world of Alzheimer\u2019s and osteoporosis. Curr Osteoporos Rep. 2024;22:152\u201364. https:\/\/doi.org\/10.1007\/S11914-023-00848-W.","journal-title":"Curr Osteoporos Rep"},{"key":"993_CR11","doi-asserted-by":"publisher","first-page":"102408","DOI":"10.1016\/J.ARR.2024.102408","volume":"99","author":"NE Wanionok","year":"2024","unstructured":"Wanionok NE, Morel GR, Fern\u00e1ndez JM. Osteoporosis and Alzheimer\u00b4s disease (or Alzheimer\u00b4s disease and Osteoporosis). Ageing Res Rev. 2024;99:102408. https:\/\/doi.org\/10.1016\/J.ARR.2024.102408","journal-title":"Ageing Res Rev"},{"key":"993_CR12","doi-asserted-by":"publisher","first-page":"E2125","DOI":"10.1212\/WNL.0000000000207220","volume":"100","author":"T Xiao","year":"2023","unstructured":"Xiao T, Ghatan S, Mooldijk SS, Trajanoska K, Oei L, Gomez MM, et al. Association of Bone Mineral Density and Dementia The Rotterdam Study. Neurology. 2023;100:E2125\u201333. https:\/\/doi.org\/10.1212\/WNL.0000000000207220","journal-title":"Neurology"},{"key":"993_CR13","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/JBMR.4402","volume":"36","author":"D Bliuc","year":"2021","unstructured":"Bliuc D, Tran T, Adachi JD, Atkins GJ, Berger C, van den Bergh J, et al. Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res. 2021;36:2106\u201315. https:\/\/doi.org\/10.1002\/JBMR.4402.","journal-title":"J Bone Miner Res"},{"key":"993_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-181249","volume":"69","author":"J Yuan","year":"2019","unstructured":"Yuan J, Meloni BP, Shi T, Bonser A, Papadimitriou JM, Mastaglia FL, et al. The potential influence of bone-derived modulators on the progression of Alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2019;69:59\u201370. https:\/\/doi.org\/10.3233\/JAD-181249.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"993_CR15","doi-asserted-by":"publisher","unstructured":"Zhou R, Guo Q, Xiao Y, Guo Q, Huang Y, Li C, et al. Endocrine role of bone in the regulation of energy metabolism. Bone Res. 2021;19. https:\/\/doi.org\/10.1038\/s41413-021-00142-4.","DOI":"10.1038\/s41413-021-00142-4"},{"key":"993_CR16","doi-asserted-by":"publisher","first-page":"100471","DOI":"10.1016\/J.COEMR.2023.100471","volume":"31","author":"S Khosla","year":"2023","unstructured":"Khosla S. Evidence in humans for bone as an endocrine organ regulating energy metabolism. Curr Opin Endocr Metab Res. 2023;31:100471. https:\/\/doi.org\/10.1016\/J.COEMR.2023.100471.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"993_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cell.2013.08.042","volume":"155","author":"F Oury","year":"2013","unstructured":"Oury F, Khrimian L, Denny CA, Gardin A, Chamouni A, Goeden N, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell. 2013;155:228\u201341. https:\/\/doi.org\/10.1016\/j.cell.2013.08.042.","journal-title":"Cell"},{"key":"993_CR18","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1084\/JEM.20171320","volume":"214","author":"L Khrimian","year":"2017","unstructured":"Khrimian L, Obri A, Ramos-Brossier M, Rousseaud A, Moriceau S, Nicot AS, et al. Gpr158 mediates osteocalcin\u2019s regulation of cognition. J Exp Med. 2017;214:2859. https:\/\/doi.org\/10.1084\/JEM.20171320.","journal-title":"J Exp Med"},{"key":"993_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/NATURE21697","volume":"543","author":"I Mosialou","year":"2017","unstructured":"Mosialou I, Shikhel S, Liu JM, Maurizi A, Luo N, He Z, et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature. 2017;543:385. https:\/\/doi.org\/10.1038\/NATURE21697.","journal-title":"Nature"},{"key":"993_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/S41413-025-00424-1","volume":"13","author":"T He","year":"2025","unstructured":"He T, Qin L, Chen S, Huo S, Li J, Zhang F, et al. Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs. Bone Res. 2025;13:49. https:\/\/doi.org\/10.1038\/S41413-025-00424-1.","journal-title":"Bone Res"},{"key":"993_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-025-00404-5","volume":"13","author":"J Yu","year":"2025","unstructured":"Yu J, Ji L, Liu Y, Wang X, Wang J, Liu C. Bone-brain interaction: mechanisms and potential intervention strategies of biomaterials. Bone Res. 2025;13:1\u201320. https:\/\/doi.org\/10.1038\/s41413-025-00404-5.","journal-title":"Bone Res"},{"key":"993_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS21144946","volume":"21","author":"E Otto","year":"2020","unstructured":"Otto E, Knapstein PR, Jahn D, Appelt J, Frosch KH, Tsitsilonis S, et al. Crosstalk of brain and bone\u2014clinical observations and their molecular bases. Int J Mol Sci. 2020;21:4946. https:\/\/doi.org\/10.3390\/IJMS21144946.","journal-title":"Int J Mol Sci"},{"key":"993_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/J.CYTOGFR.2005.02.005","volume":"16","author":"RL Van Bezooijen","year":"2005","unstructured":"Van Bezooijen RL, Ten Dijke P, Papapoulos SE, L\u00f6wik CWGM. SOST\/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev. 2005;16:319\u201327. https:\/\/doi.org\/10.1016\/J.CYTOGFR.2005.02.005.","journal-title":"Cytokine Growth Factor Rev"},{"key":"993_CR24","doi-asserted-by":"publisher","first-page":"26770","DOI":"10.1074\/jbc.M504308200","volume":"280","author":"M Sem\u00ebnov","year":"2005","unstructured":"Sem\u00ebnov M, Tamai K, He X. SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor. J Biol Chem. 2005;280:26770\u20135. https:\/\/doi.org\/10.1074\/jbc.M504308200.","journal-title":"J Biol Chem"},{"key":"993_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-020-19155-4","author":"J Kim","year":"2020","unstructured":"Kim J, Han W, Park T, Kim EJ, Bang I, Lee HS, et al. Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/S41467-020-19155-4.","journal-title":"Nat Commun"},{"key":"993_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-023-00278-5","volume":"11","author":"CR Diegel","year":"2023","unstructured":"Diegel CR, Kramer I, Moes C, Foxa GE, McDonald MJ, Madaj ZB, et al. Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5. Bone Res. 2023;11:1\u201312. https:\/\/doi.org\/10.1038\/s41413-023-00278-5.","journal-title":"Bone Res"},{"key":"993_CR27","doi-asserted-by":"publisher","first-page":"eabi5811","DOI":"10.1126\/SCIADV.ABI5811","volume":"7","author":"Z Qian","year":"2021","unstructured":"Qian Z, Li H, Yang H, Yang Q, Lu Z, Wang L, et al. Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 signaling in the mouse brain. Sci Adv. 2021;7:eabi5811. https:\/\/doi.org\/10.1126\/SCIADV.ABI5811.","journal-title":"Sci Adv"},{"key":"993_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/967673","author":"J Shao","year":"2015","unstructured":"Shao J, Wang Z, Yang T, Ying H, Zhang Y, Liu S. Bone regulates glucose metabolism as an endocrine organ through osteocalcin. Int J Endocrinol. 2015. https:\/\/doi.org\/10.1155\/2015\/967673.","journal-title":"Int J Endocrinol"},{"key":"993_CR29","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1073\/PNAS.0711119105","volume":"105","author":"M Ferron","year":"2008","unstructured":"Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates \u03b2 cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105:5266. https:\/\/doi.org\/10.1073\/PNAS.0711119105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"993_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/NRENDO.2017.181","volume":"14","author":"A Obri","year":"2018","unstructured":"Obri A, Khrimian L, Karsenty G, Oury F. Osteocalcin in the brain: from embryonic development to age-related decline in cognition. Nat Rev Endocrinol. 2018;14:174. https:\/\/doi.org\/10.1038\/NRENDO.2017.181.","journal-title":"Nat Rev Endocrinol"},{"key":"993_CR31","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1073\/pnas.72.10.3925","volume":"72","author":"PV Hauschka","year":"1975","unstructured":"Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A. 1975;72:3925\u20139. https:\/\/doi.org\/10.1073\/pnas.72.10.3925.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"993_CR32","first-page":"2615","volume":"37","author":"JB Lian","year":"1978","unstructured":"Lian JB, Hauschka PV, Gallop PM. Properties and biosynthesis of a vitamin K-dependent calcium binding protein in bone. Fed Proc. 1978;37:2615\u201320.","journal-title":"Fed Proc"},{"key":"993_CR33","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1073\/pnas.73.5.1447","volume":"73","author":"PA Price","year":"1976","unstructured":"Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A. 1976;73:1447\u201351. https:\/\/doi.org\/10.1073\/pnas.73.5.1447.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"993_CR34","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1073\/pnas.77.4.2234","volume":"77","author":"PA Price","year":"1980","unstructured":"Price PA, Nishimoto SK. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci U S A. 1980;77:2234\u20138. https:\/\/doi.org\/10.1073\/pnas.77.4.2234.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"993_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142:296\u2013308. https:\/\/doi.org\/10.1016\/j.cell.2010.06.003.","journal-title":"Cell"},{"key":"993_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/S41420-023-01343-Y","volume":"9","author":"C Shan","year":"2023","unstructured":"Shan C, Zhang D, Ma D, Hou Y, Zhuang Q, Gong Y, et al. Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer\u2019s disease by reducing amyloid \u03b2 burden and upregulating glycolysis in neuroglia. Cell Death Discov. 2023;9:46. https:\/\/doi.org\/10.1038\/S41420-023-01343-Y.","journal-title":"Cell Death Discov"},{"key":"993_CR37","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","volume":"268","author":"L Kjeldsen","year":"1993","unstructured":"Kjeldsen L, Johnsen AH, Sengel\u00f8v H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425\u201332. https:\/\/doi.org\/10.1016\/S0021-9258(18)82217-7.","journal-title":"J Biol Chem"},{"key":"993_CR38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432:917\u201321. https:\/\/doi.org\/10.1038\/nature03104.","journal-title":"Nature"},{"key":"993_CR39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","volume":"10","author":"DH Goetz","year":"2002","unstructured":"Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent that Interferes with Siderophore-Mediated Iron Acquisition. Mol Cell. 2002;10:1033\u201343. https:\/\/doi.org\/10.1016\/S1097-2765(02)00708-6","journal-title":"Mol Cell"},{"key":"993_CR40","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2217\/EPI-2019-0215","volume":"12","author":"BW Wu","year":"2020","unstructured":"Wu BW, Guo JD, Wu MS, Liu Y, Lu M, Zhou YH, et al. Osteoblast-Derived Lipocalin-2 Regulated by miRNA-96-5p\/Foxo1 Advances the Progression of Alzheimer\u2019s Disease. Epigenomics. 2020;12:1501\u201313. https:\/\/doi.org\/10.2217\/EPI-2019-0215","journal-title":"Epigenomics"},{"key":"993_CR41","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/J.DADM.2019.07.004","volume":"11","author":"E Eruysal","year":"2019","unstructured":"Eruysal E, Ravdin L, Kamel H, Iadecola C, Ishii M. Plasma lipocalin-2 levels in the preclinical stage of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2019;11:646. https:\/\/doi.org\/10.1016\/J.DADM.2019.07.004.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"993_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/S13195-021-00955-9","volume":"14","author":"P Hermann","year":"2022","unstructured":"Hermann P, Villar-Piqu\u00e9 A, Schmitz M, Schmidt C, Varges D, Goebel S, et al. Plasma lipocalin 2 in Alzheimer\u2019s disease: potential utility in the differential diagnosis and relationship with other biomarkers. Alzheimers Res Ther. 2022;14:9. https:\/\/doi.org\/10.1186\/S13195-021-00955-9.","journal-title":"Alzheimers Res Ther"},{"key":"993_CR43","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1002\/ALZ.13864","volume":"20","author":"ZT Liu","year":"2024","unstructured":"Liu ZT, Liu MH, Xiong Y, Wang YJ, Bu XL. Crosstalk between bone and brain in Alzheimer\u2019s disease: Mechanisms, applications, and perspectives. Alzheimer\u2019s & Dementia. 2024;20:5720\u201339. https:\/\/doi.org\/10.1002\/ALZ.13864.","journal-title":"Alzheimer's & Dementia"},{"key":"993_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/CNS.70016","volume":"30","author":"XS Qi","year":"2024","unstructured":"Qi XS, He X, Peng Y, He XH, Yang QY, Jiao K, et al. Roles of osteocalcin in the central nervous system. CNS Neurosci Ther. 2024;30:e70016. https:\/\/doi.org\/10.1111\/CNS.70016.","journal-title":"CNS Neurosci Ther"},{"key":"993_CR45","doi-asserted-by":"publisher","first-page":"101984","DOI":"10.1016\/J.ARR.2023.101984","volume":"89","author":"X Li","year":"2023","unstructured":"Li X, Wang X, Guo L, Wu K, Wang L, Rao L, et al. Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence. Ageing Res Rev. 2023;89:101984. https:\/\/doi.org\/10.1016\/J.ARR.2023.101984.","journal-title":"Ageing Res Rev"},{"key":"993_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/J.IJGE.2015.09.003","volume":"10","author":"F Li","year":"2016","unstructured":"Li F. Alzheimer\u2019s disease increases the incidence of hospitalization due to fall-related bone fracture in elderly Chinese. Int J Gerontol. 2016;10:227\u201331. https:\/\/doi.org\/10.1016\/J.IJGE.2015.09.003.","journal-title":"Int J Gerontol"},{"key":"993_CR47","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2174\/15672050113109990149","volume":"13","author":"D Liu","year":"2016","unstructured":"Liu D, Zhou H, Tao Y, Tan J, Chen L, Huang H, et al. Alzheimer\u2019s disease is associated with increased risk of osteoporosis: the Chongqing aging study. Curr Alzheimer Res. 2016;13:1165\u201372. https:\/\/doi.org\/10.2174\/15672050113109990149.","journal-title":"Curr Alzheimer Res"},{"key":"993_CR48","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/872173","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Shen L, Ji HF. Alzheimer\u2019s disease and risk of hip fracture: a meta-analysis study. Sci World J. 2012. https:\/\/doi.org\/10.1100\/2012\/872173.","journal-title":"Sci World J"},{"key":"993_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3233\/JAD-180569","volume":"65","author":"K Kostev","year":"2018","unstructured":"Kostev K, Hadji P, Jacob L. Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany. J Alzheimers Dis. 2018;65:401\u20137. https:\/\/doi.org\/10.3233\/JAD-180569","journal-title":"J Alzheimers Dis"},{"key":"993_CR50","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012755","author":"HG Kang","year":"2018","unstructured":"Kang HG, Park HY, Ryu HU, Suk SH. Bone mineral loss and cognitive impairment: the PRESENT project. Medicine (Baltimore). 2018. https:\/\/doi.org\/10.1097\/MD.0000000000012755.","journal-title":"Medicine (Baltimore)"},{"key":"993_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2021.786337","volume":"13","author":"MJ Kwon","year":"2021","unstructured":"Kwon MJ, Kim JH, Kim JH, Cho SJ, Nam ES, Choi HG. The occurrence of Alzheimer\u2019s disease and Parkinson\u2019s disease in individuals with osteoporosis: a longitudinal follow-up study using a national health screening database in Korea. Front Aging Neurosci. 2021;13:786337. https:\/\/doi.org\/10.3389\/FNAGI.2021.786337.","journal-title":"Front Aging Neurosci"},{"key":"993_CR52","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/1567205011666140812115818","volume":"11","author":"R Zhou","year":"2014","unstructured":"Zhou R, Zhou H, Rui L, Xu J. Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer\u2019s disease. Curr Alzheimer Res. 2014;11:706\u201313. https:\/\/doi.org\/10.2174\/1567205011666140812115818.","journal-title":"Curr Alzheimer Res"},{"key":"993_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S40520-025-03100-W","volume":"37","author":"J Lu","year":"2025","unstructured":"Lu J, Mastaglia F, Tai ACP, Bulsara MK, Blakeney WG, Inderjeeth CA, et al. Association of heel bone mineral density with incident dementia among ageing adults: a population-based study from the UK Biobank. Aging Clin Exp Res. 2025;37:1\u201310. https:\/\/doi.org\/10.1007\/S40520-025-03100-W.","journal-title":"Aging Clin Exp Res"},{"key":"993_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2023.1090223","volume":"15","author":"H Hu","year":"2023","unstructured":"Hu H, Mei J, Cai Y, Ding H, Niu S, Zhang W, et al. No genetic causal association between Alzheimer\u2019s disease and osteoporosis: a bidirectional two-sample Mendelian randomization study. Front Aging Neurosci. 2023;15:1090223. https:\/\/doi.org\/10.3389\/FNAGI.2023.1090223.","journal-title":"Front Aging Neurosci"},{"key":"993_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.NEUROBIOLAGING.2018.03.021","volume":"67","author":"CM Dengler-Crish","year":"2018","unstructured":"Dengler-Crish CM, Ball HC, Lin L, Novak KM, Cooper LN. Evidence of Wnt\/\u03b2-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2018;67:148\u201358. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2018.03.021.","journal-title":"Neurobiol Aging"},{"key":"993_CR56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/GERONA\/GLAE211","volume":"79","author":"A Nagarajan","year":"2024","unstructured":"Nagarajan A, Laird J, Ugochukwu O, Reppe S, Gautvik K, Ross RD, et al. Network Analysis of Brain and Bone Tissue Transcripts Reveals Shared Molecular Mechanisms Underlying Alzheimer\u2019s Disease and Related Dementias and Osteoporosis. Journals Gerontology: Ser A. 2024;79:211. https:\/\/doi.org\/10.1093\/GERONA\/GLAE211","journal-title":"Journals Gerontology: Ser A"},{"key":"993_CR57","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/J.GENDIS.2022.07.011","volume":"10","author":"R Vlashi","year":"2023","unstructured":"Vlashi R, Zhang X, Wu M, Chen G. Wnt signaling: essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. Genes Dis. 2023;10:1291\u2013317. https:\/\/doi.org\/10.1016\/J.GENDIS.2022.07.011.","journal-title":"Genes Dis"},{"key":"993_CR58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/J.JDSR.2007.11.002","volume":"44","author":"Y Kobayashi","year":"2008","unstructured":"Kobayashi Y, Maeda K, Takahashi N. Roles of Wnt signaling in bone formation and resorption. Japanese Dent Sci Rev. 2008;44:76\u201382. https:\/\/doi.org\/10.1016\/J.JDSR.2007.11.002.","journal-title":"Japanese Dent Sci Rev"},{"key":"993_CR59","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1073\/PNAS.0710831105","volume":"105","author":"C Zhang","year":"2008","unstructured":"Zhang C, Cho K, Huang Y, Lyons JP, Zhou X, Sinha K, et al. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci U S A. 2008;105:6936\u201341. https:\/\/doi.org\/10.1073\/PNAS.0710831105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"993_CR60","doi-asserted-by":"publisher","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, et al. Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J Biol Chem. 2005;280:19883\u20137. https:\/\/doi.org\/10.1074\/jbc.M413274200.","journal-title":"J Biol Chem"},{"key":"993_CR61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4321\/S1889-836X2014000400006","volume":"6","author":"J Delgado-Calle","year":"2014","unstructured":"Delgado-Calle J, P\u00e9rez-Campo FM, Riancho JA. Advances in the study of the mechanisms involved in the modulation of the expression of sclerostin in human cells. Revista de Osteoporos y Metabolismo Mineral. 2014;6:103\u20138. https:\/\/doi.org\/10.4321\/S1889-836X2014000400006.","journal-title":"Revista de Osteoporos y Metabolismo Mineral"},{"key":"993_CR62","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1759720X17726744","volume":"9","author":"MR McClung","year":"2017","unstructured":"McClung MR. Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential. Ther Adv Musculoskelet Dis. 2017;9:263\u201370. https:\/\/doi.org\/10.1177\/1759720X17726744","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"993_CR63","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/J.BONE.2016.12.004","volume":"96","author":"MT Drake","year":"2017","unstructured":"Drake MT, Khosla S. Hormonal and systemic regulation of sclerostin. Bone. 2017;96:8\u201317. https:\/\/doi.org\/10.1016\/J.BONE.2016.12.004.","journal-title":"Bone"},{"key":"993_CR64","doi-asserted-by":"publisher","first-page":"16744","DOI":"10.1074\/JBC.M114.628313","volume":"290","author":"JM Spatz","year":"2015","unstructured":"Spatz JM, Wein MN, Gooi JH, Qu Y, Garr JL, Liu S, et al. The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro. J Biol Chem. 2015;290:16744\u201358. https:\/\/doi.org\/10.1074\/JBC.M114.628313.","journal-title":"J Biol Chem"},{"key":"993_CR65","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/JBMR.479","volume":"26","author":"MSM Ardawi","year":"2011","unstructured":"Ardawi MSM, Al-Kadi HA, Rouzi AA, Qari MH. Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res. 2011;26:2812\u201322. https:\/\/doi.org\/10.1002\/JBMR.479.","journal-title":"J Bone Miner Res"},{"key":"993_CR66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease. Mol Psychiatry. 2021;26:10. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry 2021"},{"key":"993_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-023-00114-4","author":"J Yuan","year":"2023","unstructured":"Yuan J, Pedrini S, Thota R, Doecke J, Chatterjee P, Sohrabi HR, et al. Elevated plasma sclerostin is associated with high brain amyloid-\u03b2 load in cognitively normal older adults. NPJ Aging. 2023. https:\/\/doi.org\/10.1038\/s41514-023-00114-4.","journal-title":"NPJ Aging"},{"key":"993_CR68","doi-asserted-by":"publisher","first-page":"e70297","DOI":"10.1002\/dad2.70297","volume":"18","author":"M Dicarlo","year":"2026","unstructured":"Dicarlo M, Pignataro P, Urso D, Zecca C, Dell\u2019Abate MT, Borlizzi F, et al. Cerebrospinal fluid sclerostin levels in the early Alzheimer\u2019s disease stages. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2026;18:e70297. https:\/\/doi.org\/10.1002\/dad2.70297.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"993_CR69","doi-asserted-by":"publisher","first-page":"e70417","DOI":"10.1002\/dad2.70417","volume":"18","author":"P Pignataro","year":"2026","unstructured":"Pignataro P, Dicarlo M, Urso D, Zecca C, Colaianni G, Dell\u2019Abate MT, et al. Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer\u2019s disease continuum. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2026;18:e70417. https:\/\/doi.org\/10.1002\/dad2.70417.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"993_CR70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/JMCB\/MJT051","volume":"6","author":"NC Inestrosa","year":"2014","unstructured":"Inestrosa NC, Varela-Nallar L. Wnt signaling in the nervous system and in Alzheimer\u2019s disease. J Mol Cell Biol. 2014;6:64\u201374. https:\/\/doi.org\/10.1093\/JMCB\/MJT051.","journal-title":"J Mol Cell Biol"},{"key":"993_CR71","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0197-0186(02)00056-6","volume":"41","author":"NC Inestrosa","year":"2002","unstructured":"Inestrosa NC, De Ferrari GV, Garrido JL, Alvarez A, Olivares GH, Barr\u00eda MI, et al. Wnt signaling involvement in \u03b2-amyloid-dependent neurodegeneration. Neurochem Int. 2002;41:341\u20134. https:\/\/doi.org\/10.1016\/S0197-0186(02)00056-6.","journal-title":"Neurochem Int"},{"key":"993_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/J.NEURON.2014.08.048","volume":"84","author":"CC Liu","year":"2014","unstructured":"Liu CC, Tsai CW, Deak F, Rogers J, Penuliar M, Sung YM, et al. Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer\u2019s Disease. Neuron. 2014;84:63\u201377. https:\/\/doi.org\/10.1016\/J.NEURON.2014.08.048","journal-title":"Neuron"},{"issue":"3","key":"993_CR73","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/mp.2009.72","volume":"15","author":"EM Toledo","year":"2010","unstructured":"Toledo EM, Inestrosa NC. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1\u0394E9 mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2010;15(3):272\u201385. https:\/\/doi.org\/10.1038\/mp.2009.72.","journal-title":"Mol Psychiatry"},{"key":"993_CR74","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/J.NBD.2006.06.016","volume":"24","author":"C Scali","year":"2006","unstructured":"Scali C, Caraci F, Gianfriddo M, Diodato E, Roncarati R, Pollio G, et al. Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1. Neurobiol Dis. 2006;24:254\u201365. https:\/\/doi.org\/10.1016\/J.NBD.2006.06.016.","journal-title":"Neurobiol Dis"},{"key":"993_CR75","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/BRAINSCI10120902","volume":"10","author":"ND Aghaizu","year":"2020","unstructured":"Aghaizu ND, Jin H, Whiting PJ. Dysregulated Wnt Signalling in the Alzheimer\u2019s Brain. Brain Sci. 2020;10:902. https:\/\/doi.org\/10.3390\/BRAINSCI10120902","journal-title":"Brain Sci"},{"key":"993_CR76","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1523\/JNEUROSCI.4562-11.2012","volume":"32","author":"SA Purro","year":"2012","unstructured":"Purro SA, Dickins EM, Salinas PC. The Secreted Wnt Antagonist Dickkopf-1 Is Required for Amyloid \u03b2-Mediated Synaptic Loss. J Neurosci. 2012;32:3492\u20138. https:\/\/doi.org\/10.1523\/JNEUROSCI.4562-11.2012","journal-title":"J Neurosci"},{"key":"993_CR77","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/J.CUB.2016.07.024","volume":"26","author":"A Marzo","year":"2016","unstructured":"Marzo A, Galli S, Lopes D, McLeod F, Podpolny M, Segovia-Roldan M, et al. Reversal of synapse degeneration by restoring Wnt signaling in the adult hippocampus. Curr Biol. 2016;26:2551\u201361. https:\/\/doi.org\/10.1016\/J.CUB.2016.07.024.","journal-title":"Curr Biol"},{"key":"993_CR78","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.MEHY.2015.12.023","volume":"88","author":"X Guo","year":"2016","unstructured":"Guo X, Tang P, Liu P, Liu Y, Chong L, Li R. Dkk1: A promising molecule to connect Alzheimer\u2019s disease and osteoporosis. Med Hypotheses. 2016;88:30\u20132. https:\/\/doi.org\/10.1016\/J.MEHY.2015.12.023.","journal-title":"Med Hypotheses"},{"key":"993_CR79","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s42255-024-00989-x","volume":"6","author":"T Shi","year":"2024","unstructured":"Shi T, Shen S, Shi Y, Wang Q, Zhang G, Lin J, et al. Osteocyte-derived sclerostin impairs cognitive function during ageing and Alzheimer\u2019s disease progression. Nat Metab. 2024;6:531\u201349. https:\/\/doi.org\/10.1038\/s42255-024-00989-x.","journal-title":"Nat Metab"},{"key":"993_CR80","volume-title":"StatPearls<br>","author":"Gawdi Rohin","year":"2023","unstructured":"Gawdi R, Shumway KR, Emmady PD. Physiology, Blood Brain Barrier. [Updated 2023 Mar 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557721\/"},{"key":"993_CR81","doi-asserted-by":"publisher","DOI":"10.1385\/1592598900","volume-title":"The Proteomics Protocols Handbook","year":"2005","unstructured":"Walker J, editor. The Proteomics Protocols Handbook. 1st ed. NJ: Humana Totowa. 2005. https:\/\/doi.org\/10.1385\/1592598900","edition":"1st ed"},{"key":"993_CR82","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/S00232-015-9778-9\/TABLES\/2","volume":"248","author":"CW Fong","year":"2015","unstructured":"Fong CW. Permeability of the Blood\u2013Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds. J Membr Biol. 2015;248:651\u201369. https:\/\/doi.org\/10.1007\/S00232-015-9778-9\/TABLES\/2","journal-title":"J Membr Biol"},{"key":"993_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/S13041-019-0525-5","author":"L Jia","year":"2019","unstructured":"Jia L, Pi\u00f1a-Crespo J, Li Y. Restoring Wnt\/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease. Mol Brain. 2019. https:\/\/doi.org\/10.1186\/S13041-019-0525-5.","journal-title":"Mol Brain"},{"key":"993_CR84","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/J.METABOL.2017.10.005","volume":"80","author":"A Sebastian","year":"2018","unstructured":"Sebastian A, Loots GG. Genetics of Sost\/SOST in sclerosteosis and van Buchem disease animal models. Metabolism. 2018;80:38\u201347. https:\/\/doi.org\/10.1016\/J.METABOL.2017.10.005.","journal-title":"Metabolism"},{"key":"993_CR85","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/J.COPH.2018.04.011","volume":"40","author":"R Baron","year":"2018","unstructured":"Baron R, Gori F. Targeting WNT signaling in the treatment of osteoporosis. Curr Opin Pharmacol. 2018;40:134\u201341. https:\/\/doi.org\/10.1016\/J.COPH.2018.04.011.","journal-title":"Curr Opin Pharmacol"},{"key":"993_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2024.1411285","volume":"15","author":"S Inokuchi","year":"2024","unstructured":"Inokuchi S, Shimamoto K. Wnt\/\u03b2-catenin pathway as a potential target for Parkinson\u2019s disease: a cohort study of romosozumab using routinely collected health data in Japan. Front Pharmacol. 2024;15:1411285. https:\/\/doi.org\/10.3389\/FPHAR.2024.1411285.","journal-title":"Front Pharmacol"},{"key":"993_CR87","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/J.BONE.2019.06.027","volume":"127","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Lin J, Shao J, Zuo Q, Wang S, Wolff A, et al. Aberrant activation of Wnt signaling pathway altered osteocyte mineralization. Bone. 2019;127:324\u201333. https:\/\/doi.org\/10.1016\/J.BONE.2019.06.027.","journal-title":"Bone"},{"key":"993_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40364-021-00323-7","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhao T, Zhang S, Wang J, Chen Y, Zhao H, et al. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy. Biomark Res. 2021;9:1\u201316. https:\/\/doi.org\/10.1186\/S40364-021-00323-7.","journal-title":"Biomark Res"},{"key":"993_CR89","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/NEUONC\/NOAE176","volume":"27","author":"KH Ho","year":"2025","unstructured":"Ho KH, Trapp M, Guida C, Ivanova EL, De Jaime-Soguero A, Jabali A, et al. Activation of Wnt\/\u03b2-catenin signaling is critical for the tumorigenesis of choroid plexus. Neuro Oncol. 2025;27:106\u201322. https:\/\/doi.org\/10.1093\/NEUONC\/NOAE176.","journal-title":"Neuro Oncol"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-026-00993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-026-00993-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-026-00993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:51:21Z","timestamp":1792561881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-026-00993-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1007\/s11914-026-00993-y","relation":{},"ISSN":["1544-2241"],"issn-type":[{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Jones received personal fees and royalties as an educational consultant for Johnson & Johnson Pty Ltd, held shares in NavBit Pty Ltd and received consulting fees from Enovis Pty Ltd and Zimmer Biomet outside the submitted work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All figures and tables are original and never published before.","order":2,"name":"Ethics","label":"Prior publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"44"}}